Glaxosmi. Pharma

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE159A01016
  • NSEID: GLAXO
  • BSEID: 500660
INR
2,615.60
18.65 (0.72%)
BSENSE

Aug 12

BSE+NSE Vol: 38.6 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryGlaxosmi. Pharma VS Pharmaceuticals & Biotechnology
 
1D
0.72%
-0.75%
1W
1.91%
-1.29%
1M
7.39%
-0.01%
YTD
5.85%
-8.98%
1Y
1.03%
-3.33%
3Y
81.42%
18.74%
5Y
62.78%
41.43%
10Y
68.65%
175.52%
  • Stock Absolute Returns
  • India SENSEXAbsolute Returns
stock-summaryPrice + Dividend
Total Returns (Price + Dividend) stock-summary
Dividend Yield (2.19%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
6.84%
2.38%
9.22%
6 Months
-1.93%
2.20%
0.27%
1 Year
1.03%
2.04%
3.07%
2 Years
-9.45%
2.37%
-7.08%
3 Years
81.42%
7.18%
88.6%
4 Years
81.39%
9.26%
90.65%
5 Years
62.78%
12.94%
75.72%

Latest dividend: 57 per share ex-dividend date: May-29-2026

stock-summaryReturn Quartiles
What is a Quartile?

Quartile analysis gives a quick view of the performance of the stock with its peers and with the overall market. Companies are bucketed in 4 Quartiles as per their total returns generated; with each quartile consisting of 25% of the companies in the category.


Example: If there are 20 companies in an industry, the top 5 return giving companies would be bucketed in 1st quartile, next 5 companies in 2nd quartile and so on

Return Quartiles - by Closest Peers stock-summary
Inconsistent Performance

Glaxosmithkline Pharmaceuticals Ltd has not been a consistent performer in the YTD and longer periods

2
Quartile
quartile-2
QTD
6.16%
3
Quartile
quartile-3
Mar-Jun
7.3%
3
Quartile
quartile-3
Dec-Mar
-7.59%
4
Quartile
quartile-4
YTD
0.46%
1
Quartile
quartile-1
2025
9.98%
4
Quartile
quartile-4
2024
18.41%
Click on any of the quartiles for detailed breakdown
Return Quartiles - by Industry stock-summary
Inconsistent Performance

Glaxosmithkline Pharmaceuticals Ltd has not been a consistent performer in the YTD and longer periods

2
Quartile
quartile-2
QTD
6.16%
4
Quartile
quartile-4
Mar-Jun
7.3%
2
Quartile
quartile-2
Dec-Mar
-7.59%
2
Quartile
quartile-2
YTD
0.46%
1
Quartile
quartile-1
2025
9.98%
3
Quartile
quartile-3
2024
18.41%
Click on any of the quartiles for detailed breakdown
Return Quartiles - by Market Cap stock-summary
Inconsistent Performance

Glaxosmithkline Pharmaceuticals Ltd has not been a consistent performer in the YTD and longer periods

2
Quartile
quartile-2
QTD
6.16%
3
Quartile
quartile-3
Mar-Jun
7.3%
2
Quartile
quartile-2
Dec-Mar
-7.59%
3
Quartile
quartile-3
YTD
0.46%
2
Quartile
quartile-2
2025
9.98%
3
Quartile
quartile-3
2024
18.41%
Click on any of the quartiles for detailed breakdown
stock-summaryRisk Adjusted Returns v/s India SENSEX
Risk Adjusted Returns v/s stock-summary
stock-summaryReturns Beta
Returns Beta
Icon
Beta has not been calculated since enough price history is not available